logo

For the Inventor, By the Inventor

Vienna, Austria

Dorothea Ingrid Rudolph

This inventor holds 8 USPTO granted patents and 14 published patent applications. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dorothea Ingrid Rudolph. Retrieved from https://idiyas.com/inventor/dorothea-ingrid-rudolph

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

Average Co-Inventor Count = 3.9

ph-index = 1


Location History:

  • Wien, DE (2011)
  • Vienna, AT (2014 - 2023)

Company Filing History:

goldMedal8 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents

Years Active: 2011-2023

Loading Chart...
8 patents (USPTO):Explore Patents
1. 11814380 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors (2023-11-14),
2. 9956225 - Treatment of myelodysplastic syndrome (2018-05-01),
3. 9867831 - Combination treatment of acute myeloid leukemia and myelodysplastic syndrome (2018-01-16),
4. 9370535 - Method for treatment of advanced solid tumors (2016-06-21),
5. 9358233 - Method for treating acute myeloid leukemia (2016-06-07),
6. 8957020 - Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism (2015-02-17),
7. 8828934 - Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism (2014-09-09),
8. 8076098 - Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism (2011-12-13),

Title: The Innovative Path of Dorothea Ingrid Rudolph

Introduction:

Dorothea Ingrid Rudolph is a renowned inventor based in Vienna, Austria, with a remarkable track record in the field of pharmaceutical innovations. With a total of 8 patents to his name, his contributions have significantly impacted the medical industry.

Latest Patents:

Among his latest patents is the groundbreaking discovery of Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors. This invention holds immense potential in the treatment and prevention of oncological diseases. Additionally, Rudolph's work on the utilization of Volasertib in treating myelodysplastic syndrome showcases his dedication to advancing medical solutions.

Career Highlights:

Dorothea Ingrid Rudolph is affiliated with Boehringer Ingelheim International GmbH, a prominent pharmaceutical company known for its cutting-edge research and development initiatives. Through his role in the company, Rudolph has spearheaded various projects aimed at revolutionizing healthcare practices.

Collaborations:

In his professional journey, Rudolph has collaborated closely with esteemed colleagues such as Tillmann Taube and Arnd Steuernagel. Together, they have synergized their expertise to bring forth innovative solutions that address critical medical challenges.

Conclusion:

Dorothea Ingrid Rudolph's fervor for innovation and commitment to enhancing patient care exemplify his profound impact on the pharmaceutical landscape. His diverse portfolio of patents and collaborations underscore his invaluable contributions to the realm of medical inventions. As he continues to push boundaries and explore new frontiers, Rudolph remains a beacon of inspiration for aspiring inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…